ADORA1 and type 2 diabetes mellitus: These results suggest that the beneficial effects of chronic caffeine consumption, a non-selective adenosine receptor antagonist, in lowering the risk of develop type 2 diabetes (5–7), might be mediated by adenosine A2 receptors, with a minor contribution from A1 adenosine receptors.